Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Journal of Clinical Oncology (Impact Factor: 18.43). 08/2011; 29(23):3140-5. DOI: 10.1200/JCO.2011.35.6519
Source: PubMed

ABSTRACT To identify factors associated with outcome after surgical management of intrahepatic cholangiocarcinoma (ICC) and examine the impact of lymph node (LN) assessment on survival.
From an international multi-institutional database, 449 patients who underwent surgery for ICC between 1973 and 2010 were identified. Clinical and pathologic data were evaluated using uni- and multivariate analyses.
Median tumor size was 6.5 cm. Most patients had a solitary tumor (73%) and no vascular invasion (69%). Median survival was 27 months, and 5-year survival was 31%. Factors associated with adverse prognosis included positive margin status (hazard ratio [HR], 2.20; P < .001), multiple lesions (HR, 1.80; P = .001), and vascular invasion (HR, 1.59; P = .015). Tumor size was not a prognostic factor (HR, 1.03; P = .23). Patients were stratified using the American Joint Committee on Cancer/International Union Against Cancer T1, T2a, and T2b categories (seventh edition) in a discrete step-wise fashion (P < .001). Lymphadenectomy was performed in 248 patients (55%); 74 of these (30%) had LN metastasis. LN metastasis was associated with worse outcome (median survival: N0, 30 months v N1, 24 months; P = .03). Although patients with no LN metastasis were able to be stratified by tumor number and vascular invasion (N0; P < .001), among patients with N1 disease, multiple tumors and vascular invasion, either alone or together, failed to discriminate patients into discrete prognostic groups (P = .34).
Although tumor size provides no prognostic information, tumor number, vascular invasion, and LN metastasis were associated with survival. N1 status adversely affected overall survival and also influenced the relative effect of tumor number and vascular invasion on prognosis. Lymphadenectomy should be strongly considered for ICC, because up to 30% of patients will have LN metastasis.

Download full-text


Available from: Carlo Pulitano, Aug 20, 2015
  • Source
    • "However, extrapolating from colorectal data, [163] the prognosis of patients with ''gross'' hilar adenopathy is particularly poor with few long-term survivors . In addition to lymph node disease, the presence of either intrahepatic metastasis or major vascular invasion similarly have a 5-year survival in the range of 20% or less with the vast majority of patients experiencing a recurrence [149] [164]. Given the very poor prognosis of patients who have clinically evident lymph node metastasis, intrahepatic metastasis or major vascular invasion , these factors should be considered relatively strong contraindications to surgical resection. "
    Journal of Hepatology 06/2014; 60(6). DOI:10.1016/j.jhep.2014.01.021 · 10.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The wage inequality, specially the one resulting from discrimination against blacks and women in the labor market, is an important component of the high income concentration of the Brazilian economy. The majority of studies developed in this area adopt the hypoyhesis that the effects of atributes determining wages are constant and identical across the wage distribution. This article estimates the wage structures for each percentile of income distribution to white men, black men, white women and black women using Koenker and Bassett (1978) and Machado and Mata (2004)'s quantile regression counterfactual decomposition technique. Discrimination is positively related to the wage distribution quantile to the three groups, pointing out the difficulties facing women and black men to reach better paid jobs. The black women are the mostly affected by discrimination, followed by white women and black men. The education's return increases to higher quantiles to all groups, increasing the intra-group wage inequality. The increase in wages obtained with the equalization of education and level of formal work between the discriminated groups and white men indicate that, concerning education, black men and women would have income gains across all the distribution, especially in the higher deciles. To formal work, the population on the lower quantiles would receive the greatest benefit.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Criteria for selecting patients to receive adjuvant chemotherapy in cases of resected intrahepatic or hilar cholangiocarcinoma (CC) are lacking. Some clinicians advocate the provision of adjuvant therapy in patients with lymph node (LN)-positive disease; however, nodal assessment is often inadequate. The aim of this study was to identify a surrogate criterion based on primary tumour characteristics. Methods: All patients who underwent resection for hilar or intrahepatic CC at a single institution between January 2000 and September 2009 were identified from a prospectively maintained database. Pathological factors were recorded. The primary outcome assessed was overall survival (OS). In total, 69 patients underwent resection for hilar (n=34) or intrahepatic (n=35) CC. Their median age was 66 years and 27 patients (39%) were male. Median follow-up was 22 months and median OS was 17 months. Median tumour size was 5 cm. Overall, 23% of patients had a positive resection margin, 44% had perineural invasion, 32% had lymphovascular invasion (LVI) and 25% had positive LNs. The median number of LNs removed was two and the median number of positive LNs was zero. The presence of LVI was associated with reduced OS (11.9 months vs. 23.1 months; P=0.023). After accounting for all other adverse tumour factors, the presence of LVI persisted as the only negative prognostic factor for OS on multivariate Cox regression. In patients who had undergone resection of hilar or intrahepatic CC, the presence of LVI was strongly associated with reduced OS. Thus the finding of LVI may potentially be used as a criterion in the selection of patients for adjuvant chemotherapy.
    HPB 09/2011; 13(9):605-11. DOI:10.1111/j.1477-2574.2011.00335.x · 2.05 Impact Factor
Show more